share_log

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga ·  Sep 1, 2023 09:06

Gainers

  • Trxade Health (NASDAQ:MEDS) stock moved upwards by 99.2% to $15.22 during Friday's pre-market session. The market value of their outstanding shares is at $18.9 million.
  • Novo Integrated Sciences (NASDAQ:NVOS) shares rose 50.71% to $0.21. The company's market cap stands at $33.2 million.
  • Axcella Health (NASDAQ:AXLA) stock rose 29.3% to $0.3. The market value of their outstanding shares is at $22.0 million.
  • 23andMe Holding (NASDAQ:ME) stock rose 19.54% to $1.31. The market value of their outstanding shares is at $621.3 million.
  • Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 13.66% to $0.98. The company's market cap stands at $11.4 million.
  • Celularity (NASDAQ:CELU) stock increased by 12.34% to $0.36. The company's market cap stands at $69.5 million.

Losers

  • Aditxt (NASDAQ:ADTX) stock declined by 45.7% to $29.87 during Friday's pre-market session. The company's market cap stands at $5.6 million.
  • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares decreased by 16.65% to $6.66. The market value of their outstanding shares is at $1.5 million.
  • Acer Therapeutics (NASDAQ:ACER) shares decreased by 15.63% to $1.08. The market value of their outstanding shares is at $26.4 million.
  • Aravive (NASDAQ:ARAV) shares decreased by 8.93% to $0.14. The market value of their outstanding shares is at $9.9 million.
  • Allarity Therapeutics (NASDAQ:ALLR) stock declined by 7.57% to $1.71. The market value of their outstanding shares is at $4.6 million.
  • Xtant Medical Hldgs (AMEX:XTNT) shares decreased by 7.5% to $1.11. The market value of their outstanding shares is at $143.0 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment